CIK 0000310158 · Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 221918501
- Phone
- 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Results of operations
- 4 Grant or award EVP, General Counsel acquired 11,583 shares (grant or award)
- 4 Grant or award EVP,Chief Info&Digital Officer acquired 6,112 shares (grant or award)
- 4 Grant or award SVP Fin. - Global Controller acquired 1,066 shares (grant or award)
- 4 Grant or award President, Human Health Int?l acquired 5,703 shares (grant or award)
- 4 Grant or award President, U.S. Market acquired 5,026 shares (grant or award)
- 4 Grant or award EVP & CFO acquired 15,852 shares (grant or award)
- 4 Grant or award Executive VP & President, MRL acquired 20,469 shares (grant or award)
- 4 Grant or award Chief Marketing Officer acquired 9,865 shares (grant or award)
- 4 Grant or award EVP&Pres, Merck Animal Heallth acquired 12,264 shares (grant or award)
- 4 Grant or award Chairman, CEO & President acquired 47,434 shares (grant or award)
- 4 Grant or award Exe V-P & Pres. MMD acquired 13,880 shares (grant or award)
- SC TO-T/A Deal Tender Offer Statement
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 7 of 152 · 3,038 filings